Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
Safety, efficacy and drug survival of biologics and biosimilars for moderate-to-severe plaque psoriasis
A Egeberg, M B Ottosen, R Gniadecki, S Broesby-Olsen, T N Dam,
L E Bryld
, M K Rasmussen,
L Skov
Department of Clinical Medicine
133
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Safety, efficacy and drug survival of biologics and biosimilars for moderate-to-severe plaque psoriasis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
secukinumab
100%
Biosimilar Pharmaceuticals
86%
Psoriasis
61%
Biological Products
61%
Ustekinumab
46%
Etanercept
38%
Infliximab
36%
Safety
36%
Survival
34%
Adalimumab
29%
Pharmaceutical Preparations
19%
CT-P13
13%
Biological Factors
8%
Kaplan-Meier Estimate
7%
Registries
6%
Infections
3%
Therapeutics
2%